Abstract
‘The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?’
Highlights
As it turned out, National Center for Complementary and Alternative Medicine (NCCAM), itself came in for censure
Dr Longhurst spoke of NCCAM’s unique role in investigating modalities ignored by the rest of NIH. He favors continued research on some CAIM treatments, Dr Marcus opined that other NIH Centers are equipped to take on such projects
On the subject of the criticisms leveled at NCCAM, the speaker advocated ‘ruthless neutrality’ in all scientific investigation but suggested that in its imperfection, NCCAM in no way distinguishes itself from other NIH Centers
Summary
NCCAM, itself came in for censure. Dr Daniel Cherkin, Associate Director for Research and Senior Investigator at Group Health in Seattle functioned as moderator and began the program with a catalog of ills from which the US health care system suffers, a description of the role CAIM has played in responding to those ills, a review of NCCAM’s mission and several questions regarding how that mission has been and should be carried out. Dr Marcus made reference to neuroscientific studies, work on the placebo effect and negative trials of herbs as useful NCCAM achievements. Dr Longhurst spoke of NCCAM’s unique role in investigating modalities ignored by the rest of NIH.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
